Patents by Inventor Gyoo-yeol Jung

Gyoo-yeol Jung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11535854
    Abstract: The present invention relates to a novel microorganism capable of metabolizing various carbon sources at high rates. A novel microorganism according to the present invention was observed to grow at a very high rate in a minimal medium/nutrient medium, etc., compared to microorganisms such as Escherichia coli, and shows resistance at a high initial sugar/salt concentrations as well as being able to produce lycopene and 2,3-butanediol through genetic manipulation. Therefore, the novel microorganism can be used in various production fields of high value-added compounds using microorganisms.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: December 27, 2022
    Assignees: POSTECH ACADEMY-INDUSTRY FOUNDATION, SEOUL NATIONAL UNIVERSITY R & DB FOUNDATION
    Inventors: Gyoo Yeol Jung, Dong Hun Kwak, Sang Woo Seo, Hyun Gyu Lim
  • Publication number: 20220213540
    Abstract: The present invention relates to a novel probe set for an isothermal one-pot reaction, and uses thereof and, particularly, provides a method for easily, accurately, and quickly diagnosing molecules, in particular, infection diseases, in the field, the method having a form applicable in the field on the basis of a nucleic acid sequence by using a one-pot reaction composition under an isothermal condition. If a molecular diagnostic platform according to the present invention is used, a target sequence can be quickly and accurately detected.
    Type: Application
    Filed: April 22, 2020
    Publication date: July 7, 2022
    Inventors: Jeong Wook LEE, Gyoo Yeol JUNG, Chang Ha WOO, Sungho Jang, Giyoung SHIN
  • Patent number: 11013221
    Abstract: The present invention relates to: a transgenic Caenorhabditis elegans in which a glutamine tRNA 5? terminus-derived fragment (Gln 5?-tsRNA) is overexpressed; a preparation method therefor; and a method for screening for aging-associated factors by using the transgenic Caenorhabditis elegans. A transgenic Caenorhabditis elegans model provided in the present invention is an animal model in which Gln 5?-tsRNA is overexpressed such that aging is inhibited. When the model of the present invention is used, anti-aging mechanisms can be easily investigated, thereby significantly contributing to various research fields such as that of developing new anti-aging drugs and screening for age-inducing materials.
    Type: Grant
    Filed: April 21, 2017
    Date of Patent: May 25, 2021
    Assignees: POSTECH ACADEMY-INDUSTRY FOUNDATION, INSTITUTE FOR BASIC SCIENCE, DAEGU GYEONGBUK INSTITUTE OF SCIENCE
    Inventors: Hong Gil Nam, Gyoo Yeol Jung, Seung Jae Lee, Woo Seon Hwang, Gi Won Shin, Mi Hwa Seo
  • Publication number: 20200354755
    Abstract: The present invention relates to a novel microorganism capable of metabolizing various carbon sources at high rates. A novel microorganism according to the present invention was observed to grow at a very high rate in a minimal medium/nutrient medium, etc., compared to microorganisms such as Escherichia coli, and shows resistance at a high initial sugar/salt concentrations as well as being able to produce lycopene and 2,3-butanediol through genetic manipulation. Therefore, the novel microorganism can be used in various production fields of high value-added compounds using microorganisms.
    Type: Application
    Filed: May 11, 2018
    Publication date: November 12, 2020
    Inventors: Gyoo Yeol Jung, Dong Hun Kwak, Sang Woo Seo, Hyun Gyu Lim
  • Publication number: 20190200589
    Abstract: The present invention relates to: a transgenic Caenorhabditis elegans in which a glutamine tRNA 5? terminus-derived fragment (Gln 5?-tsRNA) is overexpressed; a preparation method therefor; and a method for screening for aging-associated factors by using the transgenic Caenorhabditis elegans. A transgenic Caenorhabditis elegans model provided in the present invention is an animal model in which Gln 5?-tsRNA is overexpressed such that aging is inhibited. When the model of the present invention is used, anti-aging mechanisms can be easily investigated, thereby significantly contributing to various research fields such as that of developing new anti-aging drugs and screening for age-inducing materials.
    Type: Application
    Filed: April 21, 2017
    Publication date: July 4, 2019
    Applicants: Postech Academy-Industry Foundation, Institute for Basic Science, Daegu Gyeongbuk Institute of Science
    Inventors: Hong Gil NAM, Gyoo Yeol JUNG, Seung Jae LEE, Woo Seon HWANG, Gi Won SHIN, Mi Hwa SEO
  • Patent number: 9919932
    Abstract: The present invention relates to a method for preparing a nickel ferrite nanoparticle composite having an inverse spinel structure obtained using a polyol process, a nickel ferrite nanoparticle composite prepared by the method, and a method for selectively binding, separating or purifying a specific protein using the nickel ferrite nanoparticle composite. The method for preparing a magnetic nanoparticle composite according to the present invention includes a one-step hydrothermal synthesis process, and thereby the magnetic nanoparticle composite can be prepared in a simple and economic manner. Also, the nickel ferrite nanoparticles synthesized by the method of the present invention can be strongly magnetic, and also exist in the form of Ni2+ in which Ni binds to a specific protein, thereby preventing loss of separability caused by additional oxidation and repeated recycling of the nanoparticles.
    Type: Grant
    Filed: March 29, 2012
    Date of Patent: March 20, 2018
    Assignee: POSTECH ACADEMY-INDUSTRY FOUNDATION
    Inventors: Gyoo Yeol Jung, Sang Woo Seo, Jinyoung Chun, Jinwoo Lee
  • Patent number: 9493767
    Abstract: A method of screening a high L-tryptophan-producing microorganism using a riboswitch is provided. More particularly, a riboswitch for screening a high L-tryptophan-producing microorganism including a tryptophan aptamer, a DNA sequence consisting of 1 to 20 nucleotides and a selectable marker gene, and a method of screening a high L-tryptophan-producing microorganism using the same are provided. The riboswitch and the method of screening a high L-tryptophan-producing microorganism using the same can be useful in selecting a strain producing a high concentration of L-tryptophan in a relatively quick and easy manner, and thus enhancing price competitiveness of tryptophan production using microorganisms.
    Type: Grant
    Filed: June 19, 2013
    Date of Patent: November 15, 2016
    Assignee: POSTECH ACADEMY-INDUSTRY FOUNDATION
    Inventors: Gyoo Yeol Jung, Jina Yang, SungHo Jang, Sang Woo Seo
  • Publication number: 20150337293
    Abstract: A method of screening a high L-tryptophan-producing microorganism using a riboswitch is provided. More particularly, a riboswitch for screening a high L-tryptophan-producing microorganism including a tryptophan aptamer, a DNA sequence consisting of 1 to 20 nucleotides and a selectable marker gene, and a method of screening a high L-tryptophan-producing microorganism using the same are provided. The riboswitch and the method of screening a high L-tryptophan-producing microorganism using the same can be useful in selecting a strain producing a high concentration of L-tryptophan in a relatively quick and easy manner, and thus enhancing price competitiveness of tryptophan production using microorganisms.
    Type: Application
    Filed: June 19, 2013
    Publication date: November 26, 2015
    Applicant: POSTECH ACADEMY-INDUSTRY FOUNDATION
    Inventors: Gyoo Yeol Jung, Jina Yang, SungHo Jang, Sang Woo Seo
  • Publication number: 20140163209
    Abstract: The present invention relates to a method for preparing a nickel ferrite nanoparticle composite having an inverse spinel structure obtained using a polyol process, a nickel ferrite nanoparticle composite prepared by the method, and a method for selectively binding, separating or purifying a specific protein using the nickel ferrite nanoparticle composite. The method for preparing a magnetic nanoparticle composite according to the present invention includes a one-step hydrothermal synthesis process, and thereby the magnetic nanoparticle composite can be prepared in a simple and economic manner. Also, the nickel ferrite nanoparticles synthesized by the method of the present invention can be strongly magnetic, and also exist in the form of Ni2+ in which Ni binds to a specific protein, thereby preventing loss of separability caused by additional oxidation and repeated recycling of the nanoparticles.
    Type: Application
    Filed: March 29, 2012
    Publication date: June 12, 2014
    Applicant: Postech Academy-Industry Foundation
    Inventors: Gyoo Yeol Jung, Sang Woo Seo, Jinyoung Chun, Jinwoo Lee
  • Publication number: 20120181175
    Abstract: The present invention relates to filler for analyzing capillary electrophoresis-based single strand conformation polymorphism, and to a method for using the filler for analyzing capillary electrophoresis-based single strand conformation polymorphism, and more particularly, to filler for analyzing capillary electrophoresis-based single strand conformation polymorphism, the filler containing a polymer micelle formed by dispersing a sandwich-block copolymer comprising (Hydrophilic group)-(Hydrophobic group)-(Hydrophilic group) in an aqueous medium, and to a method for using the filler for analyzing capillary electrophoresis-based single strand conformation polymorphism.
    Type: Application
    Filed: October 9, 2009
    Publication date: July 19, 2012
    Applicant: THE BIO CO., LTD
    Inventors: Hyun Kee Kim, Gyoo Yeol Jung, Gi Won Shin, Hee Sung Hwang
  • Patent number: 5593856
    Abstract: A method for producing protein in a cell-free system uses cell-free extract required for protein production, extracted from a biological cell. According to the present invention, a wide range of proteins can be produced economically and efficiently even in a semi-continuous operation mode, by regenerating energy source, increasing operation time of the reactor with porous solid material and using selective protein isolating means having high specific affinity to a desired protein. Thus, problems appearing in the living cell (in vivo) system due to the absence of post-translational processing can be avoided and the total production amount can be greatly increased due to prolonged operation time of the reactor and increased protein productivity.
    Type: Grant
    Filed: August 25, 1994
    Date of Patent: January 14, 1997
    Assignee: Cha-yong Choi
    Inventors: Cha-yong Choi, Dong-myung Kim, Gyoo-yeol Jung